Myrna Nahas
About Myrna Nahas
Myrna Nahas serves as the Medical Director of Clinical Development at Kite Pharma, where she has worked since 2019. She has a background in hematology and oncology, having held various positions at prestigious institutions including UCLA Health and Beth Israel Deaconess Medical Center.
Work at Kite Pharma
Myrna Nahas serves as the Medical Director of Clinical Development at Kite Pharma, a role she has held since 2019. In this position, she is responsible for overseeing clinical development strategies and ensuring the effective execution of clinical trials. Kite Pharma specializes in innovative cancer therapies, particularly in the field of cell therapy. Nahas's expertise contributes to the advancement of treatment options for patients with hematologic malignancies.
Education and Expertise
Myrna Nahas earned her Doctor of Medicine (MD) from The University of Texas Health Science Center at San Antonio, completing her studies from 2005 to 2009. Prior to this, she obtained a Bachelor of Arts (B.A.) in Biology from The University of Texas at Austin, where she studied from 2001 to 2005. Her educational background provides a strong foundation for her expertise in clinical development and hematology/oncology.
Background
Myrna Nahas has a diverse background in medicine, having worked in various capacities within the healthcare system. She completed her residency at UCLA Health from 2009 to 2012, followed by a fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center from 2013 to 2016. Additionally, she served as Chief Resident at UCLA Health for 11 months in 2012-2013 and later as an Instructor of Medicine at Beth Israel Deaconess Medical Center from 2016 to 2019.
Professional Experience
Throughout her career, Myrna Nahas has accumulated extensive experience in clinical medicine and education. At UCLA Health, she transitioned from a Resident Physician to Chief Resident, demonstrating leadership and clinical skills. Following her residency, she pursued a fellowship at Beth Israel Deaconess Medical Center, where she focused on hematologic malignancies and bone marrow transplantation. Her role as an Instructor of Medicine further highlights her commitment to educating future medical professionals.